Welcome to our dedicated page for AMERISAFE SEC filings (Ticker: AMSF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMERISAFE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMERISAFE's regulatory disclosures and financial reporting.
Ramos Guillermo A reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC executive Guillermo A. Ramos, EVP and Chief Financial Officer, received a grant of 33,003 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of AMERISAFE common stock. Following this grant, he holds 33,003 restricted stock units directly.
The award vests over four years in annual installments of 15%, 20%, 30% and 35%, beginning on May 7, 2027, the first anniversary of the grant date. This structure links a significant portion of the executive’s compensation to the company’s long-term share performance and continued service.
AMERISAFE INC executive Guillermo A. Ramos, the company’s EVP and Chief Financial Officer, filed a Form 3 as an initial statement of beneficial ownership. The filing does not list any transactions or holdings, serving primarily to register his status as a reporting officer under SEC rules.
AMERISAFE Inc reports that Vanguard Capital Management beneficially owns 994,816 shares of Common Stock, representing 5.29% of the class. The filing shows sole voting power for 145,788 shares and sole dispositive power for 994,816 shares as reported.
Lestage Henry O IV reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC granted executive compensation in stock-based form. EVP and Chief Claims Officer Henry O. Lestage IV received 1,991 restricted stock units, each representing a contingent right to one share of common stock. These restricted stock units fully vest on March 1, 2029, if vesting conditions are met.
Following this grant, Lestage directly holds 24,112 shares or share-equivalents in total, indicating this is a routine, compensation-related equity award rather than a market purchase or sale.
Lestage Henry O IV reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC reported that EVP and Chief Claims Officer Henry O. Lestage IV received a grant of 22,121 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of AMERISAFE common stock, so the award ties his compensation to future share performance.
The RSUs vest in four annual installments: 15% on March 15, 2027, 20% on March 15, 2028, 30% on March 15, 2029, and 35% on March 15, 2030. Following this grant, his reported RSU holdings under this award total 22,121 units.
AMERISAFE, Inc. is asking shareholders to vote at its June 10, 2026 annual meeting in DeRidder, Louisiana. Holders of 18,703,771 common shares as of April 16, 2026 may vote on six items, including electing three directors to terms ending at the 2029 meeting.
Shareholders will cast an advisory vote on 2025 executive pay, ratify Ernst & Young LLP as independent auditor for 2026, and consider amendments to the Certificate of Formation. One amendment would add officer exculpation to the fullest extent allowed under Texas law; another makes technical and conforming updates, including the special meeting ownership threshold.
The proxy also details board structure, committee responsibilities, director compensation and ownership guidelines, and a pay program that ties a significant portion of named executive officers’ compensation to performance-based annual and long-term incentives. In 2025, AMERISAFE reported net income of $47.1 million, a 91.3% combined ratio, earnings per diluted share of $2.47, and a return on average equity of 18.5%.
AMERISAFE, Inc. reported solid but slightly softer results for the quarter ended March 31, 2026. Net premiums earned rose 9.0% to $75.1 million and total revenues reached $80.1 million, up from $72.6 million a year earlier, reflecting growth in workers’ compensation business for hazardous industries.
Net income was $8.1 million, down modestly from $8.9 million, and diluted earnings per share were $0.43 versus $0.47. The net combined ratio deteriorated to 93.2% from 89.1% as loss and loss adjustment expenses increased, though the company still recorded $7.6 million of favorable prior-year reserve development.
AMERISAFE maintained a strong investment base, with $773.6 million in investments and cash, largely in fixed-maturity securities. Operating cash flow was a small outflow of $2.7 million. The company continued returning capital via a quarterly dividend of $0.41 per share and repurchased 119,959 shares for $4.0 million, ending with 18,703,771 shares outstanding and book value per share of $13.18.
AMERISAFE, Inc. reported first-quarter 2026 results with net premiums earned of $75.1 million, up 9.0% from 2025. Gross premiums written rose 5.6% to $88.5 million, reflecting continued growth in its workers’ compensation business focused on high-hazard industries.
Despite this growth, net income declined to $8.1 million, down 9.0%, and diluted EPS fell to $0.43. The net combined ratio worsened to 93.2% from 89.1%, as higher loss and policyholder dividend costs reduced underwriting profit. Return on average equity was 13.1%.
The company maintained active capital management, paying a quarterly dividend of $0.41 per share and repurchasing 119,959 shares for $4.0 million. Book value per share was $13.18 at March 31, 2026, modestly below year-end 2025, while management highlighted ongoing expense discipline and long-term growth objectives.
AMERISAFE, Inc. appointed Guillermo A. Ramos as Executive Vice President and Chief Financial Officer, effective May 7, 2026. He joins from Hiscox US, where he served as Head of Finance Strategy and Senior Vice President, and previously held senior finance roles at Equifax.
Ramos entered a three-year employment agreement with automatic one-year renewals, a base salary of at least $500,000, eligibility for incentive plans, and customary severance if terminated without cause, including 12 months of salary and average bonus. He will also receive restricted stock units valued at $1,000,000 under AMERISAFE’s 2022 Equity and Incentive Compensation Plan.